BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 2736835)

  • 1. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study.
    Andonopoulos AP; Drosos AA; Skopouli FN; Moutsopoulos HM
    Clin Exp Rheumatol; 1989; 7(2):203-5. PubMed ID: 2736835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sjögren's syndrome in progressive systemic sclerosis.
    Drosos AA; Andonopoulos AP; Costopoulos JS; Stavropoulos ED; Papadimitriou CS; Moutsopoulos HM
    J Rheumatol; 1988 Jun; 15(6):965-8. PubMed ID: 3418646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Sjögren's syndrome in rheumatoid arthritis.
    Andonopoulos AP; Drosos AA; Skopouli FN; Acritidis NC; Moutsopoulos HM
    J Rheumatol; 1987 Dec; 14(6):1098-103. PubMed ID: 3437415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary Sjögren's syndrome in an elderly population.
    Drosos AA; Andonopoulos AP; Costopoulos JS; Papadimitriou CS; Moutsopoulos HM
    Br J Rheumatol; 1988 Apr; 27(2):123-7. PubMed ID: 3365531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical evaluation of different clinical and serological parameters for the diagnosis of Sjögren's syndrome.
    Vitali C; Giuggioli C; Monti P; Rossi G; Wu DH; d'Ascanio A; Chiellini S; Gabriele M; Bombardieri S
    Clin Exp Rheumatol; 1989; 7(2):191-5. PubMed ID: 2736833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis.
    Osial TA; Whiteside TL; Buckingham RB; Singh G; Barnes EL; Pierce JM; Rodnan GP
    Arthritis Rheum; 1983 Apr; 26(4):500-8. PubMed ID: 6838673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological profiles in subgroups of patients with Sjögren's syndrome.
    Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to tissue transglutaminase in Sjögren's syndrome and related rheumatic diseases.
    Luft LM; Barr SG; Martin LO; Chan EK; Fritzler MJ
    J Rheumatol; 2003 Dec; 30(12):2613-9. PubMed ID: 14719202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sjögren's syndrome in systemic lupus erythematosus.
    Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and risk factors of neurological involvement in Sjögren's syndrome.
    Ye W; Chen S; Huang X; Qin W; Zhang T; Zhu X; Zhu X; Lin C; Wang X
    BMC Neurosci; 2018 Apr; 19(1):26. PubMed ID: 29703151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging of the parotid gland in patients with Sjögren's syndrome.
    Späth M; Krüger K; Dresel S; Grevers G; Vogl T; Schattenkirchner M
    J Rheumatol; 1991 Sep; 18(9):1372-8. PubMed ID: 1757940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Dry oral and ocular manifestations and autoantibodies characteristic of primary Sjögren's syndrome in multiple sclerosis".
    Hora JSI; da Silva MCR; Braga CLS; Loureiro AM; Alves ATNN; Lourenço SQC; Vasconcelos CCF
    Mult Scler Relat Disord; 2022 Jun; 62():103783. PubMed ID: 35452962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similarities and differences between primary and secondary Sjögren's syndrome.
    Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
    J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary diagnostic criteria for Sjögren's syndrome.
    Skopouli FN; Drosos AA; Papaioannou T; Moutsopoulos HM
    Scand J Rheumatol Suppl; 1986; 61():22-5. PubMed ID: 3473635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren's syndrome and keratoconjunctivitis sicca.
    Farris RL; Stuchell RN; Nisengard R
    Cornea; 1991 May; 10(3):207-9. PubMed ID: 2055025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Sjögren's-like syndrome in a cohort of HIV-1-positive patients: descriptive pathology and immunopathology.
    Kordossis T; Paikos S; Aroni K; Kitsanta P; Dimitrakopoulos A; Kavouklis E; Alevizou V; Kyriaki P; Skopouli FN; Moutsopoulos HM
    Br J Rheumatol; 1998 Jun; 37(6):691-5. PubMed ID: 9667626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
    Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sjögren's syndrome. Current aspects from a rheumatological point of view].
    Tomiak C; Dörner T
    Z Rheumatol; 2006 Oct; 65(6):505-17; quiz 518-9. PubMed ID: 17004051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.